The Online Investor
Drugs & Pharmaceuticals IPOs image Drugs & Pharmaceuticals IPOs » By The Online Investor Staff, updated Fri., Jan. 17, 7:20 PM
Recent initial public offerings in the Drugs & Pharmaceuticals IPOs category.

Slide #1. Kadmon Holdings, Inc. Initial Public Offering

Company: Kadmon Holdings, Inc.
Proposed Symbol: KDMN
Shares Offered: 6,250,000
Price Per Share: $12.00
Over-Allotment: 937,500
Description: Kadmon Holdings, Inc. today announced the pricing of its initial public offering of 6,250,000 shares of common stock at $12.00 per share, before underwriting discounts and commissions. Kadmon has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock at the initial public offering price. Kadmon's common stock is expected to begin trading on July 27, 2016, on the New York Stock Exchange under the symbol "KDMN". The offering is expected to close on August 1, 2016, subject to customary closing conditions.

IPOs: Kadmon Holdings, Inc.

List of Drugs & Pharmaceuticals IPOs in this Slideshow: Company Ticker IPO Date Regulus Therapeutics Inc. RGLS 10/4/2012 Intercept Pharmaceuticals, Inc ICPT 10/11/2012 Enanta Pharmaceuticals, Inc ENTA 3/21/2013 Atossa Genetics, Inc. ATOS 11/8/2012 Stemline Therapeutics, Inc. STML Zoetis ZTS Chimerix, Inc. CMRX 4/11/2013 Tetraphase Pharmaceuticals, Inc. TTPH GW Pharmaceuticals plc GWPH PTC Therapeutics, Inc. PTCT Epizyme, Inc. EPZM Conatus Pharmaceuticals Inc. CNAT Agios Pharmaceuticals, Inc. AGIO Onconova Therapeutics, Inc. ONTX Five Prime Therapeutics, Inc. FPRX Evoke Pharma, Inc. EVOK GlycoMimetics, Inc. GLYC Karyopharm Therapeutics Inc. KPTI MacroGenics, Inc MGNX Trevena, Inc. TRVN Xencor XNCR ADMA Biologics ADMA Aerie Pharmaceuticals AERI Cara Therapeutics CARA Kindred Bio KIN Flexion Therapeutics, Inc. FLXN Dicerna Pharmaceuticals, Inc. DRNA Ultragenyx Pharmaceutical Inc. RARE Intra-Cellular Therapies ITCI uniQure B.V. QURE Revance Therapeutics RVNC Eagle Pharmaceuticals EGRX Concert Pharmaceuticals CNCE Akebia Therapeutics AKBA Recro Pharma, Inc. REPH Phibro Animal Health Corporation PAHC Galmed Pharmaceuticals GLMD Agile Therapeutics, Inc. AGRX MediWound Ltd MDWD SCYNEXIS SCYX Phibro Animal Health Corporation PAHC Adamas Pharmaceuticals, Inc. ADMS Aldeyra Therapeutics ALDX Pfenex Inc PFNX 7/24/2014 Radius Health, Inc. RDUS Zafgen, Inc. ZFGN Zosano Pharma Corporation ZSAN Lantheus Holdings, Inc. LNTH Amphastar Pharmaceuticals, Inc. AMPH Karyopharm Therapeutics Inc. KPTI Affimed AFMD Minerva Neurosciences, Inc. NERV SAGE Therapeutics, Inc SAGE Auris Medical Holding AG EARS Ocular Therapeutix OCUL ContraFect Corporation CFRX Catalent, Inc. CTLT Marinus Pharmaceuticals, Inc. MRNS Foamix Pharmaceuticals Ltd. FOMX ProQR Therapeutics PRQR Calithera Biosciences, Inc. CALA Dermira DERM Xenon Pharmaceuticals Inc. XENE Bellicum Pharmaceuticals, Inc. BLCM Zosano Pharma Corporation ZSAN Ascendis Pharma A/S ASND Bellerophon Therapeutics BLPH Blueprint Medicines Corporation BPMC Xbiotech XBIT KemPharm, Inc. KMPH 4/16/2015 Viking Therapeutics, Inc. VKTX Collegium Pharmaceutical, Inc. COLL Ritter Pharmaceuticals, Inc. RTTR Catabasis Pharmaceuticals CATB Seres Therapeutics, Inc. MCRB Neos Therapeutics, Inc. NEOS vTv Therapeutics Inc. VTVT Intec Pharma Ltd. NTEC Zynerba Pharmaceuticals, Inc. ZYNE Aimmune Therapeutics, Inc. AIMT Nabriva Therapeutics AG NBRV Aclaris Therapeutics, Inc. ACRS CytomX Therapeutics, Inc. CTMX MyoKardia, Inc. MYOK Mesoblast Limited MESO Kitov Pharmaceuticals Holdings Ltd. KTOV Proteostasis Therapeutics, Inc. PTI Syndax Pharmaceuticals, Inc. SNDX Corvus Pharmaceuticals, Inc. CRVS Aeglea BioTherapeutics, Inc. AGLE Spring Bank Pharmaceuticals, Inc. SBPH Merus B.V. MRUS Reata Pharmaceuticals, Inc. RETA Clearside Biomedical, Inc. CLSD Selecta Biosciences, Inc. SELB Kadmon Holdings, Inc. KDMN

Drugs & Pharmaceuticals IPOs Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.